Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/07/1999US5998375 Treatment ov vasomotor disturbances such as hot flashes
12/07/1999US5998374 Clavaspirins
12/07/1999US5998372 Zinc ring protein
12/07/1999US5998371 Human selenoprotein
12/07/1999US5998370 Disorders caused by radiation therapy performed to treat diseases such as cancers and acquired immune deficiency syndrome (aids).
12/07/1999US5998369 Treatment of osteoporosis
12/07/1999US5998368 Derivatives of structurally modified VIP and pharmaceutical compositions containing them
12/07/1999US5998367 Pramlintide acetate
12/07/1999US5998366 Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
12/07/1999US5998365 Solvent system comprising a hydrophilic component, a hydrophobic component, and a surfactant, wherein the hydrophilic component is propylene carbonate or polyethylene glycol having average molecular weight of less than 1000.
12/07/1999US5998364 Component B as cicatrizant
12/07/1999US5998363 Enteral formulation: low in fat and containing protein hydrolysates
12/07/1999US5998362 Conjugates useful in the treatment of prostate cancer
12/07/1999US5998361 Polymerized hemoglobin
12/07/1999US5998205 Vectors for tissue-specific replication
12/07/1999US5998189 Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
12/07/1999US5998188 Mitogen activated protein kinase phosphatase cDNAS and their biologically active expression products
12/07/1999US5998187 Receptor tyrosine kinase
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998170 Polynucleotides encoding hepatocyte-specific members of the FGF family
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5998164 Polynucleotides encoding human G-protein coupled receptor GPRZ
12/07/1999US5998153 Detecting specific binding of the autoantibody in the sample to the epitopic peptide as indicative of the presence of the autoantibody to thyroid peroxidase in the sample from the patient.
12/07/1999US5998148 Antisense modulation of microtubule-associated protein 4 expression
12/07/1999US5998140 Complexes of cell with oligomer
12/07/1999US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999US5998136 Selection systems and methods for identifying genes and gene products involved in cell proliferation
12/07/1999US5998134 Retinoblastoma gene-cancer suppressor and regulator
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997896 Reconstituted collagen fiber segment compositions and methods of preparation thereof
12/07/1999US5997895 Dural/meningeal repair product using collagen matrix
12/07/1999US5997873 Method of preparation of heat shock protein 70-peptide complexes
12/07/1999US5997871 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
12/07/1999US5997868 Inhibition of scatter factor for blocking angiogenesis
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997865 Agonist antibodies against the flk2/flt3 receptor and uses thereof
12/07/1999US5997864 Modified factor VII
12/07/1999US5997863 Attenuation of wound healing processes
12/07/1999US5997862 Therapeutic treatment of group A streptococcal infections
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999US5997860 Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines
12/07/1999US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/07/1999US5997858 Administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact, said amount being less than an amount which induces a pathological response in the mammal when administered parenterally.
12/07/1999US5997857 Co-administration of interleukin-3 mutants with colony stimulating factors
12/07/1999US5997856 Il-2 and an effective formulating amount of a substituted cyclodextrin
12/07/1999US5997848 Methods and compositions for pulmonary delivery of insulin
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2119773C Macrophage activating factor from animal vitamin d-binding protein
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA2074943C Process for the enzymatic cleavage of recombinant proteins using iga proteases
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/07/1999CA1340846E Expression of biologically active platelet derived growth factor analogs in eucaryotic cells
12/07/1999CA1340841C Cecropin-like polypeptides with activity against gram-positive and gram-negative bacteria
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/03/1999CA2240002A1 Method of decreasing atherosclerosis and its complications
12/02/1999WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999WO1999061626A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061617A1 Interleukins-21 and 22
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061613A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999WO1999061612A1 Tumor suppressor
12/02/1999WO1999061611A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/02/1999WO1999061609A1 Calmodulin related protein
12/02/1999WO1999061608A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/02/1999WO1999061607A2 Antisense oligonucleotides for treating proliferating cells
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999WO1999061587A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999WO1999061585A1 Assays for identifying anti-metastatic and neurite-promoting agents and uses thereof
12/02/1999WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999WO1999061474A1 Purified human activin and process for producing the same
12/02/1999WO1999061473A1 Method for purification of borrelia lipoprotein ospa
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999WO1999061466A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999WO1999061465A1 Phenylalanine derivatives having vla-4 antagonistic activity
12/02/1999WO1999061464A1 Process of purifying angiogenesis inhibitors
12/02/1999WO1999061462A1 Antisense modulation of cellular adhesion molecule expression and treatment of cellular adhesion molecule-associated diseases
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061452A2 acpS
12/02/1999WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999WO1999061072A2 Methods of inhibiting clot formation
12/02/1999WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061064A1 Mammalian genes encoding 3'-5' exonuclease
12/02/1999WO1999061057A2 Molecules targeting cd40 and tumor cells
12/02/1999WO1999061055A1 Bifunctional molecules and therapies based thereon
12/02/1999WO1999061051A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999WO1999061050A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
12/02/1999WO1999061048A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS
1 ... 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 ... 3163